Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans
Open Access
- 10 September 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Pharmacogenomics Journal
- Vol. 14 (3), 223-228
- https://doi.org/10.1038/tpj.2013.34
Abstract
Using a derivation cohort (N=349), we developed the first warfarin dosing algorithm that includes recently discovered polymorphisms in VKORC1 and CYP2C9 associated with warfarin dose requirement in African Americans (AAs). We tested our novel algorithm in an independent cohort of 129 AAs and compared the dose prediction to the International Warfarin Pharmacogenetics Consortium (IWPC) dosing algorithms. Our algorithm explains more of the phenotypic variation (R2=0.27) than the IWPC pharmacogenomics (R2=0.15) or clinical (R2=0.16) algorithms. Among high-dose patients, our algorithm predicted a higher proportion of patients within 20% of stable warfarin dose (45% vs 29% and 2% in the IWPC pharmacogenomics and clinical algorithms, respectively). In contrast to our novel algorithm, a significant inverse correlation between predicted dose and percent West African ancestry was observed for the IWPC pharmacogenomics algorithm among patients requiring 60 mg per week (β=−2.04, P=0.02).Keywords
This publication has 42 references indexed in Scilit:
- Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyThe Lancet, 2013
- Development of a Panel of Genome-Wide Ancestry Informative Markers to Study Admixture Throughout the AmericasPLoS Genetics, 2012
- Role of Pharmacogenomics in the Management of Traditional and Novel Oral AnticoagulantsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011
- The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African AmericansCancer Cell, 2011
- A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African AmericansClinical Pharmacology & Therapeutics, 2010
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic DataNew England Journal of Medicine, 2009
- The largest prospective warfarin-treated cohort supports genetic forecastingBlood, 2009
- Characterizing the admixed African ancestry of African AmericansGenome Biology, 2009
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinCancer Cell, 2008
- Bleeding Complications With Warfarin UseArchives of Internal Medicine, 2007